Principal Display Panel (10 mL Vial Carton)
Bavencio Injection, Solution, Concentrate
Product Images NDC 44087-3535
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bavencio (NDC 44087-3535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Avelumab 02
This appears to be a graph showing the Progression-Free Survival Time (in months) for two different treatments: Avelumab + Axifnib and Sunifinb. The X-axis shows the time in months while the Y-axis shows the number of patients at risk. The numbers next to the X-axis indicate the months being tracked. There are two lines plotted on the graph, with one line indicating the survival rate for patients receiving Avelumab + Axifnib and the other line indicating the survival rate for patients receiving Sunifinb.*
Avelumab 03
BAVENCIO® is an injection medication with 200mg/10ml (20mg/ml) concentration for intravenous infusion. This single-dose vial is for Rx only and any unused portion should be discarded. A medication guide enclosed in the package must be dispensed to each patient. NDC number for this product is 44087-3535-1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
